The 14th APFCB congress (14th Asia–Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress), which is organized by APFCB (Asian-Pacific Federation for Clinical Biochemistry and laboratory Medicine ), IFCC (International Federation of Clinical Chemistry and Laboratory Medicine), CACB(Chinese Association for Clinical Biochemistry) and sponsored by many professional societies and organizations, such as AACC,EFLM and so on, is held in Taipei, Taiwan from Nov. 26th to Nov. 29th, 2016.
Snibe, as a leader in Chinese IVD market, not only sponsor this APFCB congress as a platinum sponsor, but also become a corporate member of the APFCB organization and organizes workshop during the congress.
During the APFCB congress, Snibe brings MAGLUMI 800 and MAGLUMI 2000 PLUS, as typical products from its immunoassay system. MAGLUMI 800 is suitable to small labs and mid-size hospitals with its compact design, but throughput of maximum 120 tests/ hour and up to 144 samples on board capability; while MAGLUMI 2000 PLUS can meet the needs of large labs, chain labs and hospitals with its throughput of maximum 180 tests/hour and up to 144 samples on board capability. Biossays 360, the latest products from biochemistry system, is also exhibited and attracted visitors’ attentions.
Snibe, focusing on the R&D of immunoassay products for more than 20 years and launched its integrated systems and biochemistry system these years as well, has exported to 100 countries and installed more than 6000 units all around the world and gets positive feedbacks continually. With its mission and vision to be a pioneer in global diagnosis field, Snibe never stop its step in improving human health life.
Snibe, Chemiluminescence Immunoassay Focused Manufacturer in Shenzhen, China.